Topic: chief medical officer
Former Merck clinical research leader Arthur Santora is coming out of retirement to serve as chief medical officer of Entera Bio.
Radius Health brought on Charles Morris to be CMO and oversee its expansion into oncology, with two breast cancer treatments in early-phase trials.
Sanofi VP Riccardo Perfetti has jumped to metabolic disease startup Applied Therapeutics to become its CMO as it moves into first-in-human trials.
Sensei Biotherapeutics named Ildiko Csiki as CMO. Csiki was previously VP of immuno-oncology clinical development at Inovio Pharmaceuticals.
Sanofi’s global head of diabetes late-stage development, Eckhard Leifke, will move to Omeros to be its CMO and VP of clinical development.
Beijing’s CANbridge Life Sciences, developing Western drug candidates in China and Asia, brought on Pfizer’s May Orfali to be chief medical officer.
Sublimity Therapeutics hired Jesse Hall as chief medical officer, as it looks to move its lead candidate into a phase 2b ulcerative colitis study.
T-cell developer Tmunity named Immunocore’s Christina Coughlin as CMO as it preps for early cancer studies after raising $135 million in VC funding.
Syntimmune has named Vertex’s Mario Saltarelli as chief medical officer, following several leadership changes at the company over the past 18 months.
Ablynx CMO Robert Zeldin is moving to Acceleron, to take over for longtime CMO Matthew Sherman, as it begins to get phase 3 data on luspatercept.